Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Consort's nicotine delivery device deal with BAT to be "largest single revenue opportunity"

This article was originally published in Clinica

Executive Summary

UK drug delivery device specialist Consort Medical this morning announced its subsidiary Bespak has struck a multi-year contract to be the exclusive supplier of an innovative nicotine inhalation device for Nicoventures, a unit within the world's number two tobacco player, the giant British American Tobacco. The product incorporates Bespak's proprietary valve, and is designed to be a safer alternative to smoking.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts